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Aim: Brucellosis is an important disease in developing countries. We aimed to determine the epidemiologic, clinical, and laboratory
characteristics of brucellosis, which still has a high morbidity in Turkey.
Materials and methods: Seventy-two patients with brucellosis, monitored at our clinic from January 2004 to July 2010, were reviewed
retrospectively.
Results: The average age was determined to be 44.8 ± 18 years, and 40 of the patients were female (55.6%). The most frequent transmission
route was the use of raw milk and dairy products, in 45 of the patients (62.5%). The most frequent complaints were joint pain, high
fever, weakness, low back pain, and gastrointestinal symptoms, whereas the most frequent physical examination findings were fever,
osteoarticular involvement, splenomegaly, hepatomegaly, and lymphadenopathy. All of the patients were positive for Rose Bengal
testing. The standard tube agglutination titer was 1/160 or higher in 64 (88.9%) patients. Brucella melitensis was isolated from blood
cultures of 13 (18.1%) patients and bone marrow cultures of 7 (9.7%) patients. Complications of sacroiliitis in 6 (8.3%), spondylodiscitis
in 4 (5.6%), endocarditis in 2 (2.8%), neurobrucellosis in 1 (1.4%), and epididymo-orchitis in 1 (1.4%) of the patients were observed.
Conclusion: Brucellosis has various clinical presentations. It should be included in the differential diagnosis of high fever and joint
pains in endemic countries.
Key words: Brucellosis, clinical manifestations of brucellosis, complications of brucellosis

1. Introduction
Brucellosis is a zoonotic disease caused by Brucella spp.
(1). Human brucellosis remains the most common
zoonotic disease worldwide, with more than 500,000 new
cases annually. Its prevalence is more than 1/10,000 in
the populations of some endemic countries (2). Although
it can be seen in any part of the world, the disease is
hyperendemic in the Mediterranean region consisting of
Portugal, Spain, southern France, Italy, Greece, Turkey,
and North Africa countries, as well as in the Arabian
Peninsula, India, Mexico, and Central and South America
(2,3). Brucellosis has been eradicated in England, in many
northern European countries, and in Australia, New
Zealand, and Canada (2). The prevalence of brucellosis
in Turkey has been reported to be in the range of 1% to
26.7%, depending on the geographical region (4).
The transmission route is through direct or indirect
animal contact. In particular, farmers, shepherds,
veterinarians, butchers, and laboratory personnel are at
risk of this infection (5). The disease typically takes hold
* Correspondence: suheyla.serin@gmail.com
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in young and middle-aged adults. It has a lower incidence
in childhood and the elderly (6). Although brucellosis
is more prevalent in men due to occupational risk in
countries with a low incidence of the disease, it is known
that there is no sex difference in countries where it is
endemic (3).
Human brucellosis is a multisystemic disease with
a broad spectrum of symptoms, although it can be
asymptomatic as well. Brucellosis begins as a flu-like
disease with symptoms such as fever, headache, malaise,
back pain, myalgia, and generalized aches. Splenomegaly;
hepatomegaly; gastrointestinal signs such as anorexia,
nausea, vomiting, diarrhea, and constipation; coughing;
and pleuritic chest pain can be seen. The most common
complications are arthritis, spondylitis, epididymoorchitis, and chronic fatigue. Endocarditis is one of the most
serious complications of brucellosis. Some other organs
are also affected, resulting in lymphadenopathy, deep
vein thrombosis, granulomatous hepatitis, osteomyelitis,
anemia, thrombocytopenia, and nephritis (6).
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In the present study we aimed to describe some
demographic, epidemiologic, clinical, and laboratory
characteristics of patients with brucellosis in Turkey,
which is an endemic area for brucellosis, which still has
high morbidity.
2. Materials and methods
This study evaluated 72 brucellosis patients hospitalized
and monitored at the Clinic for Infectious Diseases and
Clinical Microbiology in İzmir Tepecik Education and
Research Hospital from January 2004 to July 2010. The
information pertaining to the patients was obtained
through retrospective examination of the follow-up
forms and patient records. The brucellosis diagnosis was
made through clinical symptoms and findings, standard
tube agglutination test, and/or isolation of Brucella spp.
in clinical specimens including blood and bone marrow.
Significant titers were determined to be ≥1/160 in the
standard tube agglutination test (STA) (7).
An automated blood culture system (the BacT/ALERT
3D system, bioMérieux, Durham, NC, USA) was used for
isolation of Brucella spp. from blood and bone marrow
specimens. A Vitec 2 compact system (bioMerieux, Marcy
l’Etoile, France) was used for identification and antibiotic
susceptibility. Routine laboratory tests were done, including
complete blood count, erythrocyte sedimentation rate,
C-reactive protein levels, liver profiles including aspartate
aminotransferase and alanine transaminase, renal function
profiles, and urine examination.
The data were statistically analyzed using SPSS 18.0.
3. Results
In this study, 72 brucellosis patients were reviewed. Of the
patients, 40 (55.6%) were female. The mean age was 44.8
± 18 (range: 14–83). Twenty-eight patients (38.9%) were
from rural regions and 44 (61.1%) were from the city center.
The most prevalent transmission routes were identified as
the use of raw milk and dairy products in 45 of the patients
(62.5%), stockbreeding in 27 (37.5%), and consumption
of raw milk and dairy products in conjunction with
stockbreeding in 18 (25%) patients. Household contact was
observed in 5 (6.9%) of the patients. Among the patients
included in the study, the most frequently presented
complaints were high fever, joint pain, weakness, low back
pain, and gastrointestinal complaints (lack of appetite,
abdominal pain, and vomiting) (Table 1).
The most frequently observed findings in physical
examination of the patients were high fever, osteoarticular
involvement,
splenomegaly,
hepatomegaly,
and
lymphadenopathy (Table 2).
All of the patients tested positive in Rose Bengal testing
(+), whereas 64 (88.9%) had 1/160 titers or higher for the
Wright test. Brucella spp. was isolated from blood cultures

Table 1. Most frequent complaints.
Symptoms

Number (%)

Joint pains

27 (37.5%)

High fever

26 (36.1%)

Low back pain

19 (26.4%)

Weakness

17 (23.6%)

Headache

9 (12.5%)

Lack of appetite

9 (12.5%)

Abdominal pain

7 (9.7%)

Nausea and vomiting

7 (9.7%)

Sweating

7 (9.7%)

Loss of weight

2 (2.8%)

Pain and edema in testes

1 (1.4%)

Table 2. Most frequently identified clinical findings and
complications
Clinical findings and complications

Number (%)

Clinical findings
Fever

28 (38.9)

Splenomegaly

10 (13.9)

Lymphadenopathy

5 (6.9)

Hepatomegaly

4 (5.6)

Complications
Sacroiliitis

6 (8.3)

Spondylodiscitis

4 (5.6)

Endocarditis

2 (2.8)

Neurobrucellosis

1 (1.4)

Epididymo-orchitis

1 (1.4)

of 13 (18.1%) patients and from the bone marrow of 7
patients (9.7%). All isolates were identified as Brucella
melitensis.
Out of the patients, significant anemia was detected
in 28 (38.8%) and high serum transaminase levels in
20 (27.8%). Fourteen (19.4%) patients presented with
complicated diseases, including sacroiliitis in 6 (8.3%),
spondylodiscitis in 4 (5.6%), endocarditis in 2 (2.8%),
neurobrucellosis in 1 (1.4%), and epididymo-orchitis in 1
(1.4%). Systematic findings are shown in Table 3.
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Table 3. Systematic findings of the patients.
Systematic findings

Number (%)

Hemopoietic system
Anemia

26 (36.1)

Leukopenia

3 (4.2)

Leukocytosis

4 (5.6)

Thrombocytopenia

5 (6.9)

Gastrointestinal system
Increased serum transaminase levels

20 (27.8)

Osteoarticular
Sacroiliitis

6 (8.3)

Spondylodiscitis

4 (5.6)

Genitourinary system
Epididymo-orchitis

1(1.4)

Cardiovascular system
Endocarditis

2 (2.8)

Central nervous system
Neurobrucellosis

1 (1.4)

The patients were treated with various combinations of
antibiotics depending on clinical presentation, drug side
effects, and tolerability. The antibiotics were administered
for at least 6 weeks; in the case of spondylodiscitis,
neurobrucellosis, or endocarditis and for those with
therapeutic failure, the duration of treatment continued
for up to 1 year. Out of the patients, 42 (58.3%) received
doxycycline (200 mg/day orally) plus rifampin (600
mg/day orally) treatment, whereas 19 (26.4%) received
doxycycline (200 mg/day orally), rifampin (600 mg/day
orally), and streptomycin (1 g/day intramuscularly for
3 weeks); 4 (5.6%) received doxycycline (200 mg/day
orally), rifampin (600 mg/day orally), and ceftriaxone
(2 g/day intravascularly/intramuscularly); 3 (4.2%)
received doxycycline (200 mg/day orally), rifampin (600
mg/day orally), and levofloxacin (500 mg/day orally);
3 (4.2%) received doxycycline (200 mg/day orally) and
streptomycin (1 g/day intramuscularly for 3 weeks); and 1
(1.4%) received ciprofloxacin (500 mg twice a day orally)
and streptomycin (1 g/day intramuscularly for 3 weeks).
4. Discussion
Among high-risk patients in the eastern part of Turkey,
seropositivity has been reported to be as high as 27.2% (8).
However, the true rates of brucellosis in endemic countries
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are most probably higher than reported due to deficiencies
in its diagnosis or recording (9).
Brucellosis affects the productive age group, thus
leading to significant morbidity and economic losses,
particularly in endemic countries such as Turkey (10).
In various studies conducted in Turkey, the mean age of
patients with brucellosis was seen to range between 33
and 46.7 years (11–13). In this study, the mean age was
identified as 44.8 years and found to be concordant with
other studies. Although brucellosis is more prevalent
in men due to occupational risk in countries with a low
incidence of the disease, it is known that there is no sex
difference in countries where it is endemic (14). Out of the
patients, 40 (55.6%) were female in this study.
As brucellosis is a disease transmitted through animals
and animal products, it is seen more frequently in rural
areas. Various studies conducted in Turkey demonstrated
that most of the patients with brucellosis presented from
rural areas (15–17), whereas, in the present study, 28
(38.9%) of the patients presented from a village and 44
(61.1%) were from the city center. We believe that this may
be attributed to high immigration into İzmir Province and
the connections of the individuals living in urban regions
with those from rural areas.
Consumption of raw dairy products such as raw milk
and fresh cheese, contact with animals, and contact in the
laboratory environment are the dominant risk factors for
brucellosis (1). In Turkey, the main transmission source
for brucellosis is consumption of unpasteurized milk and
dairy products, as is the cases in other countries where the
disease is endemic (3). In our study, the consumption of raw
milk and dairy products was the case in 50 (69.4%) of the
patients. No laboratory-originated transmission was found.
Household contact can be observed due to factors such as
common dietary habits and contact with animals. In this
study, household contact was observed in 5 patients (6.9%).
Brucellosis may present with various symptoms (1).
The patients most frequently present with complaints of
high fever, weakness, sweating, joint pains, and lack of
appetite (3,6). Among the patients included in this study,
the most frequently observed complaints were high fever,
joint pain, weakness, low back pain, and gastrointestinal
complaints (lack of appetite, abdominal pain, and
vomiting). Therefore, it is believed that brucellosis should
be included in the differential diagnosis of patients with
complaints of high fever and joint and low back pain.
Physical examination findings also vary depending on the
organs involved, and the most common clinical finding is
reported as fever (1). In the physical examination of the
present study, high fever, joint findings, splenomegaly,
hepatomegaly, and lymphadenomegaly were detected.
Brucella epididymo-orchitis was diagnosed in one patient
who presented the complaint of swelling in the testes.

KÖSE et al. / Turk J Med Sci
The specific diagnosis of brucellosis is made upon isolation
of Brucella spp. in samples such as blood, bone marrow,
cerebrospinal fluid, synovial fluid, peritoneal and pleural
fluid, and sperm, or through the presence of titers of 1/160 and
higher in a standard tube agglutination test in the presence
of the appropriate clinical presentation (6). Since Brucella
spp. grows relatively slowly and to culture the organisms is
difficult, the standard tube agglutination test is considerably
more reliable in the diagnosis of brucellosis when evaluated
together with a consistent clinical presentation (18). In the
present study, while Rose Bengal test positivity was detected
in all of the patients, the standard tube agglutination test
was detected positive at 1/160 and higher in 64 (88.9%) of
the patients. In the study by Buzgan et al., the STA test was
positive in 967 (94.1%) cases, with titers ranging from 1/160
to 1/163. Forty-nine cases (4.8%) that had a negative STA were
found to be positive by Coombs STA. Twelve cases (1.2%)
were seronegative with a negative agglutination test (11).

The isolation of Brucella spp. from blood, bone
marrow, or other clinical specimens is required for a
definite diagnosis. However, due to the sensitivity of blood
culture methods it varies between 15% and 70% (19).
Thus, clinicians often rely on the indirect diagnostic tests
of brucellosis (20). Brucella spp. was isolated in blood and
bone marrow samples from 13 (18.1%) and 9 patients
(12.5%), respectively. Significant anemia was detected in
28 (38.8%) of the patients. Liver involvement is common in
brucellosis. However, transaminase levels may be normal
or there may be a mild increase (6). In this study, serum
transaminase levels were detected as high in 20 (27.8%)
patients.
In conclusion, brucellosis remains a disease with
high morbidity in Turkey. As can be observed in various
clinical presentations, brucellosis should be included in
the differential diagnosis in patients with high fever and
joint pain who have the risk factors in endemic countries.
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